Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocortisone | 11 | 2018 | 187 | 1.730 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2016 | 88 | 1.570 |
Why?
|
| Pituitary-Adrenal System | 6 | 2016 | 60 | 0.870 |
Why?
|
| Spouses | 4 | 2018 | 38 | 0.760 |
Why?
|
| Object Attachment | 4 | 2013 | 18 | 0.750 |
Why?
|
| Marriage | 3 | 2016 | 23 | 0.720 |
Why?
|
| Gender Identity | 1 | 2020 | 62 | 0.690 |
Why?
|
| Stress, Psychological | 6 | 2017 | 442 | 0.680 |
Why?
|
| Interpersonal Relations | 8 | 2020 | 150 | 0.670 |
Why?
|
| Transgender Persons | 1 | 2020 | 62 | 0.660 |
Why?
|
| Depression | 5 | 2018 | 829 | 0.610 |
Why?
|
| Mental Health | 1 | 2020 | 336 | 0.570 |
Why?
|
| Biomarkers | 1 | 2020 | 1306 | 0.480 |
Why?
|
| Adaptation, Psychological | 3 | 2007 | 259 | 0.470 |
Why?
|
| Anxiety | 2 | 2016 | 387 | 0.430 |
Why?
|
| Saliva | 8 | 2016 | 100 | 0.370 |
Why?
|
| Family Characteristics | 2 | 2020 | 43 | 0.320 |
Why?
|
| Temperament | 1 | 2007 | 20 | 0.280 |
Why?
|
| Arousal | 1 | 2007 | 41 | 0.280 |
Why?
|
| Adolescent | 11 | 2018 | 5851 | 0.260 |
Why?
|
| Courtship | 1 | 2006 | 5 | 0.260 |
Why?
|
| Family Conflict | 2 | 2018 | 6 | 0.260 |
Why?
|
| Negotiating | 1 | 2006 | 14 | 0.260 |
Why?
|
| Premature Birth | 2 | 2017 | 108 | 0.250 |
Why?
|
| Female | 21 | 2020 | 30766 | 0.250 |
Why?
|
| Emotions | 1 | 2007 | 215 | 0.230 |
Why?
|
| Sex Characteristics | 4 | 2016 | 197 | 0.220 |
Why?
|
| Male | 14 | 2020 | 27784 | 0.220 |
Why?
|
| Wounds and Injuries | 1 | 2006 | 229 | 0.220 |
Why?
|
| Self-Injurious Behavior | 1 | 2003 | 45 | 0.210 |
Why?
|
| Adult | 13 | 2018 | 15697 | 0.200 |
Why?
|
| Vitamin D | 2 | 2014 | 132 | 0.190 |
Why?
|
| Young Adult | 9 | 2018 | 4274 | 0.180 |
Why?
|
| Sex Factors | 3 | 2016 | 935 | 0.180 |
Why?
|
| Humans | 21 | 2020 | 59457 | 0.170 |
Why?
|
| Machine Learning | 1 | 2020 | 154 | 0.150 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2018 | 9 | 0.150 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2016 | 13 | 0.130 |
Why?
|
| Family Relations | 1 | 2016 | 21 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 181 | 0.130 |
Why?
|
| Pregnancy | 3 | 2018 | 2215 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1188 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2017 | 84 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 380 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 247 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 187 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2517 | 0.110 |
Why?
|
| Antidepressive Agents | 2 | 2012 | 212 | 0.110 |
Why?
|
| Social Perception | 1 | 2013 | 38 | 0.110 |
Why?
|
| alpha-Amylases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2016 | 279 | 0.110 |
Why?
|
| Premenstrual Syndrome | 1 | 2014 | 96 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 364 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 373 | 0.100 |
Why?
|
| Calcium | 2 | 2014 | 557 | 0.100 |
Why?
|
| Salivary alpha-Amylases | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cholecalciferol | 1 | 2012 | 26 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2018 | 3072 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2013 | 189 | 0.090 |
Why?
|
| Vitamins | 1 | 2012 | 74 | 0.090 |
Why?
|
| Exercise | 1 | 2018 | 883 | 0.090 |
Why?
|
| Models, Psychological | 2 | 2013 | 94 | 0.090 |
Why?
|
| Attention | 1 | 2012 | 146 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2011 | 222 | 0.080 |
Why?
|
| Cognition | 1 | 2012 | 454 | 0.070 |
Why?
|
| Diet | 1 | 2011 | 497 | 0.070 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2017 | 27 | 0.070 |
Why?
|
| Individuality | 1 | 2007 | 21 | 0.070 |
Why?
|
| Puerto Rico | 2 | 2017 | 134 | 0.070 |
Why?
|
| Massachusetts | 2 | 2018 | 2022 | 0.070 |
Why?
|
| Affect | 1 | 2006 | 123 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 403 | 0.060 |
Why?
|
| Self Report | 2 | 2020 | 359 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 903 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 1286 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2014 | 748 | 0.040 |
Why?
|
| Middle Aged | 5 | 2016 | 16338 | 0.040 |
Why?
|
| Logistic Models | 2 | 2014 | 1236 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 381 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2341 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7432 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 10 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 56 | 0.040 |
Why?
|
| Dominican Republic | 1 | 2017 | 21 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 17 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 24 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 34 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 177 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 43 | 0.030 |
Why?
|
| Helping Behavior | 1 | 2013 | 5 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 191 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 284 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 299 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 41 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 451 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 364 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 715 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 1926 | 0.020 |
Why?
|
| Postmenopause | 1 | 2011 | 224 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2377 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 979 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1258 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 13427 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2383 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 4990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5287 | 0.010 |
Why?
|